UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047406
Receipt number R000054063
Scientific Title Study of Strictly Organization Beside AF in Niigata
Date of disclosure of the study information 2022/04/06
Last modified on 2023/04/06 09:10:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of Strictly Organization Beside AF in Niigata

Acronym

SOBANI-AF study

Scientific Title

Study of Strictly Organization Beside AF in Niigata

Scientific Title:Acronym

SOBANI-AF study

Region

Japan


Condition

Condition

Atrial fibrillation

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to reduce the non-examination rate by introducing a new method of recommending examinations for those who have undergone occupational medical examinations who have been diagnosed with atrial fibrillation. Achieving this will lead to the establishment of a system to improve the treatment of patients with atrial fibrillation in the prefecture by inducing appropriate treatment for untreated patients. We would like to build an organic relationship between medical examination institutions, on-the-job doctors, and hospitals, and develop it as one of the central projects for cardiovascular disease control in Niigata Prefecture.

Basic objectives2

Others

Basic objectives -Others

In December 2018, the "Basic Law Concerning Measures for Stroke, Heart Disease and Other Cardiovascular Diseases to Extend Healthy Life Expectancy" (hereinafter referred to as "Basic Law for Cardiovascular Disease Countermeasures") was enacted. Based on this law, the Basic Plan for Promotion of Cardiovascular Disease Countermeasures was approved by the Cabinet in October 2020, and each prefecture will formulate a prefectural plan for stroke and cardiovascular disease according to the local circumstances. .. The Niigata Prefectural Cardiovascular Disease Countermeasures Promotion Council was established in 2021, and it was confirmed that the cooperation of medical examinations including medical examination institutions for the treatment of atrial fibrillation in Niigata Prefecture would be reconstructed to improve the health of the citizens of the prefecture. Was done.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of examinees who had an electrocardiogram of atrial fibrillation in the medical examination and checked "under treatment" in the item of Q5 "heart disease" of the specific medical examination questionnaire of the next year, the next year when atrial fibrillation was pointed out. The treatment rate is calculated by dividing by the number of people who have undergone a medical examination.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Those who have not been treated for atrial fibrillation (those who have no check in the following past / current medical history and those who have a check in the history and who have been diagnosed with atrial fibrillation on the electrocardiogram) are targeted.

If the letter of introduction is not sent to the Niigata Prefectural Occupational Health Medical Association 3 months after the letter is sent, contact the company's health manager and ask for a medical examination again.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

A person diagnosed with atrial fibrillation by electrocardiogram
In addition, those who have no check or have a check in the history of atrial fibrillation in the history of atrial fibrillation check column.

Key exclusion criteria

In "Handling of personal information" at the time of occupational medical examination, some disagreement items, (6) Research aimed at improving medical education and public health (in this case, individuals can be identified. Those who have undergone a medical examination with a check mark.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Takayuki
Middle name
Last name Inomata

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Cardiovascular Medicine

Zip code

951-8510

Address

757 ichiban-cho, asahimachi-dori, chuo-ku, niigata

TEL

025-227-2185

Email

inotaka@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name Kiminori
Middle name
Last name Kato

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Prevention of Noncommunicable Diseases and Promotion of Health Checkup

Zip code

951-8510

Address

757 ichiban-cho, asahimachi-dori, chuo-ku, niigata

TEL

025-227-2185

Homepage URL


Email

kkato48@med.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name



Funding Source

Organization

Niigata University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Niigata University

Address

757 ichiban-cho, asahimachi-dori, chuo-ku, niigata

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 03 Month 23 Day

Date of IRB

2022 Year 03 Month 23 Day

Anticipated trial start date

2022 Year 04 Month 06 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 05 Day

Last modified on

2023 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054063


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name